1.
Medicina (Kaunas)
; 57(11)2021 Oct 21.
Artículo
en Inglés
| MEDLINE
| ID: mdl-34833360
RESUMEN
Both clinical-pathological and experimental studies have shown that chemokines play a key role in activating the immune checkpoint modulator in cervical cancer progression and are associated with prognosis in tumor cell proliferation, invasion, angiogenesis, chemoresistance, and immunosuppression. Therefore, a clear understanding of chemokines and immune checkpoint modulators is essential for the treatment of this disease. This review discusses the origins and categories of chemokines and the mechanisms that are responsible for activating immune checkpoints in cervical dysplasia and cancer, chemokines as biomarkers, and therapy development that targets immune checkpoints in cervical cancer research.
Asunto(s)
Neoplasias del Cuello Uterino , Quimiocinas , Femenino , Humanos , Pronóstico
2.
MMW Fortschr Med
; 161(14): 43-47, 2019 Aug.
Artículo
en Alemán
| MEDLINE
| ID: mdl-31414431